Arizona moved a step closer to excluding federally regulated research facilities from animal cruelty laws yesterday after the Senate National Resources, Infrastructure and Public Debt Committee voted in favour of such a move.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments PharmaNet, Cardinal Health, CTI, Norwich, Diteba and Catalent.
BioStorage Technologies has come up with a novel solution to cold-chain transport, launching a mobile biorepository that is capable of transporting samples across the continental US on a single tank of fuel.
Contract services major Quintiles will sell Movetis’ chronic constipation treatment Resolor (prucalopride) in Europe under a contract announced last week.
PRA International has entered into a partnership with Oncopartners and IBPC to accelerate the planning, start-up and patient recruitment of oncology trials in Latin America.
Full-year income at the Lonza was hit by falling demand for life science ingredients and custom manufacturing services and only modest gains for its bioscience unit.
The global market for RFID products and services in the pharma industry will be worth $884m (€631m) in 2015, according to a report, but apprehensions about initial costs and return-on-investment need to be overcome.
Environmental certification of production facilities should be introduced to GMP legislation and sustainability risk assessments linked to marketing authorisations, according to a MPA report.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Vasella stepping down as CEO of Novartis and appointments at Shionogi Pharma and Antares Pharma.
MDS believes its early stage business is likely to sell for less than previously expected because of the continued deterioration of market conditions and its declining customer base.
Merck KGaA has begun work on a new inorganic salts plant in Darmstadt, Germany, citing growing demand as the main motivation for the €30m ($42m) investment.
The SPMC of Sri Lanka is seeking a $10m (€7.1m) loan to buy high-speed tablet and capsule filling machines and ensure it can meet the island’s demand for safe medicines.
OmniComm has connected its TrialMaster EDC system to Microsoft (MS) HealthVault, allowing health records and data to be transferred to a patient’s file during clinical trials.
Detection of Mycoplasma contamination in biologics manufacture can be cut from up to 35 days to four hours using Millipore’s MilliPROBE, according to the company.
The Formulation Innovation Network has been set up in the North of England as a means of enhancing innovation for all formulation-orientated businesses.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Synexus, INC and a Quintiles executive being elected at CDISC.
Dr Reddy’s Laboratories is combining some of its products with Aegis Therapeutics’ Intravail drug delivery technology after the companies entered into a partnership.
US CRO PPD has sold its biomarker discovery sciences unit to Caprion Proteomics, bucking the trend that has seen many of its sector rivals invest in this part of the contract research market.
Indian CRO Ankur Drugs and Pharma is a step closer to stating production of Romaco’s Siebler StripTabs now the German firm developed a fully integrated manufacturing line.
Emergency relief groups in Haiti can expect to receive continued support from the drug industry, according to the International Federation of Pharmaceutical Manufacturers (IFPMA).
Indian drugmaker Lupin can start seeking US approval for new drugs made at its API plant in Mandideep, Bhopal after resolving the cGMP deficiencies that earned the facility a US FDA warning last year.
DSM Speciality Intermediates (DSI) is to close by the end of 2010, with activities at its production site ceasing in July, in response to pricing pressures caused by the rise of rivals in India and China.
Pharmaceutical packaging machinery manufacturer Sepha has reported a 33 per cent increase in sales for 2009, underpinned by strong growth in Asia and South America.
MDS Pharma Services has adopted SAS Drug Development to allow for closer collaboration with sponsors and provide a centralised, integrated system for data management and analysis.
AMRI’s plant in Rensselaer, New York gained SafeBridge potent compound certification this week after an effort that spokesperson Andrea Schulz said istestament to the firm's "willingness to go the extra mile”.
Malgorzata Szerszeniewska, CEO of Central and Eastern Europe’s (CEE) “newest” CRO EastHorn, says maintaining ethical standards is crucial to sustaining the rapid patient recruitment rates that characterise the region.
Blow-moulded packaging companies Pretium Packaging and Novapak Corporation have been taken over by New-York-based buyout firm Castle Harlan Inc in a deal worth $200m.
Quotient Bioresearch has secured the supply of 14C labelled compounds for its customers ahead of its move to a new purpose built facility in Cardiff through an extension of its agreement with GE Healthcare (GEHC).
Microbiology testing company Nelson Laboratories has completed its 50,000 sq ft expansion and estimated it will create as many as 300 jobs over the next decade, with up to 100 appointments being made this year.
The EFPIA’s European Vaccine Manufacturers (EVM) group has denied allegations that its members were involved in hyping up the threat of the H1N1 pandemic to boost vaccine sales.
Johnson & Johnson (J&J) has expanded its US OTC drug recall after revealing that many more products than first thought may be contaminated by the wood dye, 2,4,6-tribromoanisole (TBA).
Fujitsu has launched a SaaS-based data management system which it claims can speed up clinical trials, eliminate set up and maintenance costs and allow CROs and sponsors to use the same IT environment.
The subsidy package used to attract Amylin to Ohio was probably too large and inflated by the biotech’s claim it was considering other locations, according to a report which calls for an end to the “economic war among states”.
Quintiles Transnational has selected US ePRO solutions provider Invivodata to help it meet growing regulatory pressure to focus on the patient perspectives during trials.
